Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-026310

Sr VP/Chief Commercial Officer acquired 11,600 shares (grant or award)

  • Sr VP/Chief Commercial Officer gave up 1,959 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2017-04-07 Grant or award +11,600 $6.45 $74,820 142,516 D
Cearnal Martin E Sr VP/Chief Commercial Officer 2017-04-07 Shares withheld for taxes −1,959 $6.45 $12,636 140,557 D
Loading xslF345X03/doc4.xml…